-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - .17 In addition, the existence of
a Part D coverage gap before reaching the
catastrophic coverage phase … coverage
limit (pre-ICL), initial coverage limit
(ICL), and catastrophic coverage phase us-
ing the … Claims were submitted for the highest
average number of unique medications during the pre-ICL
phase … The pre-
ICL phase showed similar trends to the deductible phase,
with all categories having approximately … , meaning some people
have no days in this phase before reaching
the pre-ICL phase.29 Many plans also
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Results
The table below lists the three topics for which (1) preliminary phase III data for drugs were … Five phase III trials on secukinumab for treating AS are ongoing. … Five phase III trials on lesinurad have been completed, and two phase III extension trials
are ongoing … Four phase III trials on secukinumab for treating PsA are ongoing. … In the phase III MEASURE 1 trial, patients (n=371) with
active AS who were intolerant of or did not
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
August 09, 2012 - We
invited 11 stakeholders to participate in the phase 2 Delphi process. … Gaps
Phase IIa
Stakeholder identification of
key topics for prioritization
Phase Ilb
Delphi … Of the 16 stakeholders interviewed in phase 1, 11 were invited to take part in phase 2 of our
study. … Phase 2
Questions for the first round of the phase 2 prioritization were based on the categories and … themes (listed above) that were identified in phase 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Results
The table below lists the single topic for which (1) at least preliminary phase III data were … In phase III clinical trials,
significantly more patients treated with lesinurad in combination with … Four phase III trials on lesinurad have been completed, and two phase III extension trials
are ongoing … In two replicate phase III trials, CLEAR 1 (n=603) and CLEAR 2 (n=610), patients received
lesinurad … Ardea Biosciences announces positive top-line
results from phase 2b combination study of
RDEA594
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
June 01, 2010 - Functionality (Phase 1)
In phase 1, functionality should include the ability to securely distribute … Phase 2: Network Expansion
The next phase, which should follow as soon as practicable, should expand … Functionality (Phase 2)
In phase 2, the flexibility of the menu-driven interface should be expanded … Phase 3: Network Maturation
The final phase of network development could be completed within four to … Phase 1: Network Initiation
2.3.2. Phase 2: Network Expansion
2.3.3.
-
effectivehealthcare.ahrq.gov/products/cancer-communication/research
March 28, 2013 - Structured Abstract
Background
This is a second-phase project sponsored by AHRQ and the National … Phase 1 developed a framework for measuring patient- centered communication (PCC) in cancer care, including … Objectives
The goal of Phase 2 was to refine the Phase 1 framework; identify, develop, and test PCC
-
effectivehealthcare.ahrq.gov/products/grades-predictive-values/abstract
September 14, 2015 - The project consisted of two main phases:
Phase 1: Comparison of Effects as Evidence Evolves From … Phase 2: Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study … The goal of this phase is to address the three objectives of this methods project. … To address the first objective, we used data gathered through Phase 1 to calculate the proportion of
-
effectivehealthcare.ahrq.gov/products/distributed-network-ambulatory-therapeutics/research
July 28, 2009 - We used the Ingenix/ICHIS Impact database for Phase 1. … Phase 2 was a replication of the same study using DARTNet data. … We used the Ingenix/ICHIS Impact database for Phase 1. … Phase 2 was a replication of the same study using DARTNet data. … Phase 2 results are summarized as follows.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - antidepressants differ in their efficacy or
effectiveness for preventing relapse (i.e., continuation phase … of depression
using these second generation antidepressants – where KQ1 addresses the acute
phase … and KQ2 the continuation or maintenance phase. … Definition of Terms
Acute Phase: first phase of depression management, usually 6 to 12 weeks in length … Continuation Phase: second phase of depression management during which the
treatment goal is continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
November 01, 2016 - Results
The table below lists the single topic for which (1) preliminary phase III data for drugs were … Three phase III trials are ongoing. … from a completed phase III trial, M12-665.10 That trial (n=872) is evaluating the change in
pain, … A global phase 3 study to evaluate the
safety and efficacy of elagolix in subjects with
moderate … Elagolix treatment for endometriosis-associated
pain: Results from a phase 2, randomized, double-
-
effectivehealthcare.ahrq.gov/products/iom-standards/white-paper
April 10, 2013 - Methods
A two-phase approach is adopted, where in phase one, 13 EPC directors, in consultation with … identified areas where general agreement exist and where further deliberation was necessary, and in phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
November 01, 2016 - Results
The table below lists the single topic for which (1) preliminary phase III data for drugs were … Four phase III trials are ongoing. … According to a manufacturer press release, positive
preliminary results reported from one phase III … A global phase 3 study to evaluate the
safety and efficacy of elagolix in subjects with
moderate … Elagolix treatment for endometriosis-associated
pain: Results from a phase 2, randomized, double-
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Results
The table below lists the single topic for which (1) preliminary phase III data for drugs (or … II/III or phase III clinical trials. … The manufacturer considers the phase I data
encouraging enough that it plans to advance directly to … a phase III trial later this year. … U.S. and European investigators are leading phase II and II/III clinical trials
studying intranasal
-
effectivehealthcare.ahrq.gov/products/antidepressants-update/research-protocol
July 13, 2011 - ) or recurrence (i.e., maintenance phase) when a patient continues the drug they initially responded … of depression using these second generation antidepressants – where KQ1 addresses the acute phase and … KQ2 the continuation or maintenance phase. … Definition of Terms
Acute Phase: first phase of depression management, usually 6 to 12 weeks in length … Continuation Phase: second phase of depression management during which the treatment goal is continued
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
January 28, 2016 - A number of other manufacturers also have
all-oral HCV DAA regimens in phase II or phase III development … Grazoprevir/elbasvir is being evaluated in several phase II and III
trials for treating chronic HCV … Four additional phase III trials on grazoprevir/elbasvir are ongoing. … In a phase III study,
patients with HCV genotype 1 infection achieved an average SVR12 rate of 92%. … In the phase III ION studies, patients achieved SVR12 rates of 94% to 99%.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-key-question.pdf
December 19, 2023 - Cruickshank C, Hassan S, Pugh J, Dearnaley DP, Hall
E; 10-Year efficacy and co-morbidity outcomes of a phase … radiotherapy for prostate cancer
(PACE-B): 2-year toxicity results from an open-label, randomised, phase … Patient-Reported Outcomes in the Acute Phase
of the Randomized Hypofractionated Irradiation for Prostate … Analysis of the Prostate Cancer
Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase … for High-Risk
Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase
-
effectivehealthcare.ahrq.gov/products/medical-tests-proposals/research
-
effectivehealthcare.ahrq.gov/products/medical-tests-proposals
November 09, 2009 - Proposals for a Phased Evaluation of Medical Tests
Timeline
November 09, 2009
Topic Initiated
November 09, 2009
Research Report
Proposals for a Phased Evaluation of Medical Tests
-
effectivehealthcare.ahrq.gov/products/distributed-network-expansion
April 03, 2012 - Distributed Research Network (DRN) Infrastructure to Support Studies of Comparative Effectiveness – Phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Four phase III trials are ongoing. … Four phase III trials are ongoing. … Two phase III trials are
ongoing. … GSK presents mepolizumab phase
III results in ERS. [internet]. … A phase 3 trial of pirfenidone in patients with
idiopathic pulmonary fibrosis.